Attributes | Values |
---|
rdf:type
| |
Description
| - The purpose of this study was to use the proteomics approach, which is based on high resolution two-dimensional electrophoresis coupled with multivariate correspondence analysis and mass spectrometry, to classify objectively the biochemical basis of the anti-cancer activity of the synthetic cyclin-dependent kinase inhibitor, bohemine.
- The purpose of this study was to use the proteomics approach, which is based on high resolution two-dimensional electrophoresis coupled with multivariate correspondence analysis and mass spectrometry, to classify objectively the biochemical basis of the anti-cancer activity of the synthetic cyclin-dependent kinase inhibitor, bohemine. (en)
- Cílem této studie bylo využít proteomického výzkumu, který byl založen na high resolution two-dimensional electrophoréze spolu s multivariate correspondence analýzou a hmotnostní spektrometrií, abychom objektivně klasifikovali biochemický základ protirakovinné aktivity syntetických cyclin-dependentních kinás inhibitorů, boheminu. (cs)
|
Title
| - Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine
- Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine (en)
- Aplikace proteomického výzkumu v oblasti hlednání nových proteinů vázaných na protirakovinným účinkem synthetických cyclin-dependentních kinás inhibitorů, boheminu (cs)
|
skos:prefLabel
| - Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine
- Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine (en)
- Aplikace proteomického výzkumu v oblasti hlednání nových proteinů vázaných na protirakovinným účinkem synthetických cyclin-dependentních kinás inhibitorů, boheminu (cs)
|
skos:notation
| - RIV/61989592:15110/02:00007101!RIV09-MSM-15110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GA301/02/0475), P(GA303/02/0875), P(KSK5052113), S, Z(AV0Z5020903), Z(AV0Z5045916), Z(MSM 151100001)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/02:00007101
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - proteomics; anti-cancer effect; cyclin-dependent kinases inhibitor; bohemine (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Technology in Cancer Research & Treatment
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Džubák, Petr
- Halada, Petr
- Hajdúch, Marián
- Man, Petr
- Kovářová, Hana
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |